X0306 4 2022-01-03 0 0001770787 10x Genomics, Inc. TXG 0001786391 Hindson Benjamin J. C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 1 1 0 0 See Remarks Class A Common Stock 2022-01-03 4 M 0 2084 11.48 A 162770 D Class A Common Stock 2022-01-03 4 M 0 39582 74.58 A 202352 D Class A Common Stock 2022-01-03 4 S 0 2300 144.5556 D 200052 D Class A Common Stock 2022-01-03 4 S 0 16464 145.4338 D 183588 D Class A Common Stock 2022-01-03 4 S 0 17396 146.2938 D 166192 D Class A Common Stock 2022-01-03 4 S 0 2906 147.3366 D 163286 D Class A Common Stock 2022-01-03 4 S 0 2000 148.4355 D 161286 D Class A Common Stock 2022-01-03 4 S 0 600 149.2433 D 160686 D Stock Option (right to buy) 11.48 2022-01-03 4 M 0 2084 0.00 D 2029-05-10 Class A Common Stock 2084 31250 D Stock Option (right to buy) 74.58 2022-01-03 4 M 0 39582 0.00 D 2030-04-21 Class A Common Stock 39582 93630 D The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $143.89 to $144.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $144.89 to $145.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $145.89 to $146.8725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $146.89 to $147.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $147.93 to $148.925. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $149.09 to $149.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This option, originally for 100,000 shares, of which 68,750 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option, originally for 136,000 shares, of which 42,370 shares have been exercised, vested as to 1/48th of the shares on May 1, 2020 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Chief Scientific Officer and President /s/ Eric S. Whitaker, as Attorney-in-Fact 2022-01-05